| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +1% |
| 3Y CAGR | +6% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -38% |
| 3Y CAGR | +36% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,388.70 +2.40 (0.10%) | 18,154.63 | 25.93 | 4.65 | ||
PfizerPFIZER | ₹3,847.40 -17.00 (0.44%) | 17,676.01 | 20.57 | 4.03 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,031.50 -407.00 (6.32%) | 16,078.00 | 90.47 | 18.29 | ||
Natco PharmaNATCOPHARM | ₹810.45 +1.65 (0.20%) | 15,866.06 | 13.86 | 1.51 |